Abhinav Bhalaik, Armaan Patkar 
Dealstreet

Argus Partners advises MedGenome on ~₹400 crore Series E fundraise

MedGenome is a genomic diagnostics and research services company.

Bar & Bench

MedGenome Inc. has raised ~₹400 crore ($47.5 million) from a Series E fundraise co-led by Maj Invest and existing investor Novo Holdings, with participation from Sofina Ventures.

Argus Partners advised MedGenome on this fundraise.

The transaction team consisted of Abhinav Bhalaik (Partner), Armaan Patkar (Partner), Ishita Agarwal (Senior Associate) and Anoushka Goel (Associate).

MedGenome

MedGenome is a genomic diagnostics and research services company.

The fundraise will enable MedGenome to broaden access to its genomics and integrated diagnostics solutions across India and other emerging markets. The funding will further strengthen MedGenome’s efforts to reduce India’s disease burden through early detection and targeted disease management using affordable, genetics-based diagnostic tools.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Chhattisgarh court grants bail to two Kerala nuns in forced conversion case

Madras High Court bars use of living persons' names, former CMs' photos, party symbols in govt scheme ads

AZB, Khaitan, JSA act on Schneider Electric's $6.4 billion stake acquisition in Schneider Electric India from Temasek

GLC was ours before you: Justice Gautam Patel slams Principal for notice against podcast run by alumni

Delhi High Court quashes bailable warrants against The Morning Context editor, director

SCROLL FOR NEXT